Parker D A, Marino V, Krishna M, Narayanan A, de la Lande I S
Dental School, The University of Adelaide, South Australia 5005, Adelaide, Australia.
Arch Oral Biol. 2000 Oct;45(10):827-31. doi: 10.1016/s0003-9969(00)00059-5.
The effects of putative presynaptic P1- and/or P2-purinoceptors on the release of noradrenaline from sympathetic nerves in human dental pulp were examined by testing the effects of agonists and an antagonist of these receptors on the stimulation-induced overflow of [(3)H]noradrenaline from tissue treated with desipramine (0.3 micromol/l) and preincubated with [(3)H]noradrenaline (0.6 micromol/l). The P1-purinoceptor agonists adenosine (1.0 mmol/l) and 2-chloroadenosine (0.01-1.0 mmol/l) and the antagonist 8-cyclopentyl-1,3-dipropyl xanthine (1.0 micromol/l), and the P2-purinoceptor agonists ATP (0.1 mmol/l) and beta, gamma-methylene-ATP (0.01 mmol/l), did not modulate the release of noradrenaline. Adenosine was also without effect in dental pulp treated with the alpha(2)-adrenoceptor antagonist rauwolscine. It is concluded that presynaptic P1-purinoceptors and those P2-purinoceptors activated by adenine nucleotides are either not present on sympathetic nerves in human dental pulp or that they exert little or no effect on the release of noradrenaline.
通过检测这些受体的激动剂和拮抗剂对去甲丙咪嗪(0.3微摩尔/升)处理并用[³H]去甲肾上腺素(0.6微摩尔/升)预孵育的组织中刺激诱导的[³H]去甲肾上腺素溢出的影响,研究了假定的突触前P1和/或P2嘌呤受体对人牙髓交感神经去甲肾上腺素释放的作用。P1嘌呤受体激动剂腺苷(1.0毫摩尔/升)和2-氯腺苷(0.01 - 1.0毫摩尔/升)以及拮抗剂8-环戊基-1,3-二丙基黄嘌呤(1.0微摩尔/升),还有P2嘌呤受体激动剂ATP(0.1毫摩尔/升)和β,γ-亚甲基-ATP(0.01毫摩尔/升),均未调节去甲肾上腺素的释放。在α₂肾上腺素能受体拮抗剂萝芙辛处理的牙髓中,腺苷也没有作用。结论是,突触前P1嘌呤受体以及由腺嘌呤核苷酸激活的那些P2嘌呤受体要么不存在于人牙髓的交感神经上,要么它们对去甲肾上腺素的释放几乎没有影响。